Tinzaparin vs Warfarin for Acute Venous Thromboembolism

被引：1
|
作者：
Maruyama, Anna [1 ]
Tejani, Aaron M. [2 ]
Perry, Thomas L. [2 ]
机构：
[1] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Therapeut Initiat, Vancouver, BC V6T 1Z3, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 315卷 / 02期
关键词：
D O I：
10.1001/jama.2015.15067
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [31] PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT - WARFARIN VS DEXTRAN-40
    HARRIS, WH
    SALZMAN, EW
    DESANCTIS, RW
    COUTTS, RD
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 220 (10) : 1319 - +
  • [32] Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
    Alexander T. Cohen
    Janvi Sah
    Amol D. Dhamane
    Dionne M. Hines
    Theodore Lee
    Lisa Rosenblatt
    Birol Emir
    Allison Keshishian
    Huseyin Yuce
    Xuemei Luo
    Advances in Therapy, 2023, 40 (4) : 1705 - 1735
  • [33] A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study
    Lee, Agnes Y. Y.
    Kamphuisen, Pieter W.
    Meyer, Guy
    Bauersachs, Rupert
    Janas, Mette S.
    Jarner, Mikala F.
    Khorana, Alok A.
    BLOOD, 2014, 124 (21)
  • [34] Effectiveness and Safety of Direct Oral Anticoagulants vs. Warfarin and Recurrence After Discontinuation in Patients With Acute Venous Thromboembolism in the Real World
    Hara, Nobuhiro
    Lee, Tetsumin
    Nozato, Toshihiro
    Matsuyama, Mao Terui
    Okata, Shinichiro
    Nagase, Masashi
    Mitsui, Kentaro
    Nitta, Giichi
    Watanabe, Keita
    Miyazaki, Ryoichi
    Nagamine, Sho
    Kaneko, Masakazu
    Nakamura, Tomofumi
    Nagata, Yasutoshi
    Miyamoto, Takamichi
    Obayashi, Toru
    Ashikaga, Takashi
    CIRCULATION JOURNAL, 2022, 86 (06) : 923 - +
  • [35] Safety of dabigatran vs. warfarin for acute venous thromboembolism: pooled analyses of RE-COVER and RE-COVER II
    Schulman, S.
    Eriksson, H.
    Goldhaber, S. Z.
    Kakkar, A.
    Kearon, C.
    Mismetti, P.
    Schellong, S.
    Feuring, M.
    Peter, N.
    Friedman, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 225 - 226
  • [36] ACUTE VENOUS THROMBOEMBOLISM
    LUDERS, K
    FORTSCHRITTE DER MEDIZIN, 1978, 96 (16) : 859 - 864
  • [37] Long-term tinzaparin versus warfarin for treatment of venous thromboembolism (VTE) in cancer patients - analysis of renal impairment (RI) in the catch study
    Bauersachs, R.
    Lee, A. Y. Y.
    Kamphuisen, P. W.
    Meyer, G.
    Janas, M. S.
    Jarner, M. F.
    Khorana, A. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 76 - 76
  • [38] THERAPY OF ACUTE THROMBOEMBOLISM WITH HEPARIN AND WARFARIN
    CARTER, BL
    CLINICAL PHARMACY, 1991, 10 (07): : 503 - 518
  • [39] Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
    Trujillo-Santos, Javier
    Farge-Bancel, Dominique
    Pedrajas, Jose Maria
    Gomez-Cuervo, Covadonga
    Ballaz, Aitor
    Braester, Andrei
    Mahe, Isabelle
    Villalobos, Aurora
    Antonio Porras, Jose
    Monreal, Manuel
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (04)
  • [40] Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery
    Tseng, E. K.
    Kolesar, E.
    Handa, P.
    Douketis, J. D.
    Anvari, M.
    Tiboni, M.
    Crowther, M. A.
    Siegal, D. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) : 2008 - 2015
12345